Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Gross Margin (2019 - 2025)

Pulmonx (LUNG) has disclosed Gross Margin for 7 consecutive years, with 74.65% as the latest value for Q3 2025.

  • Quarterly Gross Margin rose 95.0% to 74.65% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 73.3% through Sep 2025, down 86.0% year-over-year, with the annual reading at 74.0% for FY2024, 9.0% up from the prior year.
  • Gross Margin for Q3 2025 was 74.65% at Pulmonx, up from 72.11% in the prior quarter.
  • The five-year high for Gross Margin was 75.21% in Q1 2022, with the low at 71.52% in Q1 2021.
  • Average Gross Margin over 5 years is 73.79%, with a median of 73.99% recorded in 2021.
  • The sharpest move saw Gross Margin soared 4644bps in 2021, then tumbled -235bps in 2023.
  • Over 5 years, Gross Margin stood at 74.78% in 2021, then dropped by -3bps to 72.51% in 2022, then increased by 3bps to 74.7% in 2023, then fell by -1bps to 74.02% in 2024, then increased by 1bps to 74.65% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 74.65%, 72.11%, and 72.51% for Q3 2025, Q2 2025, and Q1 2025 respectively.